Literature DB >> 27755975

Probing bulky ligand entry in engineered archaeal ferritins.

Lorenzo Calisti1, Irene Benni1, Matilde Cardoso Trabuco1, Paola Baiocco2, Barbara Ruzicka3, Alberto Boffi4, Elisabetta Falvo5, Francesco Malatesta1, Alessandra Bonamore6.   

Abstract

BACKGROUND: A set of engineered ferritin mutants from Archaeoglobus fulgidus (Af-Ft) and Pyrococcus furiosus (Pf-Ft) bearing cysteine thiols in selected topological positions inside or outside the ferritin shell have been obtained. The two apo-proteins were taken as model systems for ferritin internal cavity accessibility in that Af-Ft is characterized by the presence of a 45Å wide aperture on the protein surface whereas Pf-Ft displays canonical (threefold) channels.
METHODS: Thiol reactivity has been probed in kinetic experiments in order to assess the protein matrix permeation properties towards the bulky thiol reactive DTNB (5,5'-dithiobis-2-nitrobenzoic acid) molecule.
RESULTS: Reaction of DTNB with thiols was observed in all ferritin mutants, including those bearing free cysteine thiols inside the ferritin cavity. As expected, a ferritin mutant from Pf-Ft, in which the cysteine thiol is on the outer surface displays the fastest binding kinetics. In turn, also the Pf-Ft mutant in which the cysteine thiol is placed within the internal cavity, is still capable of full stoichiometric DTNB binding albeit with an almost 200-fold slower rate. The behaviour of Af-Ft bearing a cysteine thiol in a topologically equivalent position in the internal cavity was intermediate among the two Pf-Ft mutants. CONCLUSIONS AND GENERAL SIGNIFICANCE: The data thus obtained indicate clearly that the protein matrix in archaea ferritins does not provide a significant barrier against bulky, negatively charged ligands such as DTNB, a finding of relevance in view of the multiple biotechnological applications of these ferritins that envisage ligand encapsulation within the internal cavity.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Binding kinetics; Ferritin; Nano-scaffold; Self-assembly

Mesh:

Substances:

Year:  2016        PMID: 27755975     DOI: 10.1016/j.bbagen.2016.10.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  4 in total

1.  Excimer based fluorescent pyrene-ferritin conjugate for protein oligomerization studies and imaging in living cells.

Authors:  Irene Benni; Matilde Cardoso Trabuco; Enrico Di Stasio; Alessandro Arcovito; Alberto Boffi; Francesco Malatesta; Alessandra Bonamore; Simone De Panfilis; Valeria de Turris; Paola Baiocco
Journal:  RSC Adv       Date:  2018-04-03       Impact factor: 4.036

2.  Cryo-EM structure of the human ferritin-transferrin receptor 1 complex.

Authors:  Linda Celeste Montemiglio; Claudia Testi; Pierpaolo Ceci; Elisabetta Falvo; Martina Pitea; Carmelinda Savino; Alessandro Arcovito; Giovanna Peruzzi; Paola Baiocco; Filippo Mancia; Alberto Boffi; Amédée des Georges; Beatrice Vallone
Journal:  Nat Commun       Date:  2019-03-08       Impact factor: 14.919

3.  Self-assembling ferritin-dendrimer nanoparticles for targeted delivery of nucleic acids to myeloid leukemia cells.

Authors:  Federica Palombarini; Silvia Masciarelli; Alessio Incocciati; Francesca Liccardo; Elisa Di Fabio; Antonia Iazzetti; Giancarlo Fabrizi; Francesco Fazi; Alberto Macone; Alessandra Bonamore; Alberto Boffi
Journal:  J Nanobiotechnology       Date:  2021-06-09       Impact factor: 10.435

4.  Engineered ferritin for lanthanide binding.

Authors:  Lorenzo Calisti; Matilde Cardoso Trabuco; Alberto Boffi; Claudia Testi; Linda Celeste Montemiglio; Amédée des Georges; Irene Benni; Andrea Ilari; Bartłomiej Taciak; Maciej Białasek; Tomasz Rygiel; Magdalena Król; Paola Baiocco; Alessandra Bonamore
Journal:  PLoS One       Date:  2018-08-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.